Feasibility and Efficacy of Local Radiotherapy With Concurrent Novel Agents in Patients With Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility and Efficacy of Local Radiotherapy With Concurrent Novel Agents in Patients With Multiple Myeloma

Published:2014-12 Issue:6 Volume:14 Page:480-484
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Shin Samuel M.,Chouake Robert J.,Sanfilippo Nicholas J.,Rapp Timothy B.,Cook Perry,Formenti Silvia C.,Mazumder Amitabha,Silverman Joshua S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Bone destruction and hypercalcemia in plasma cell myeloma;Mundy;Semin Oncol,1986

2. Bisphosphonates in multiple myeloma;Kanis;Cancer,2000

3. Clinical trials of bisphosphonates in multiple myeloma;Mahindra;Clin Adv Hematol Oncol,2012

4. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease;Terpos;J Clin Oncol,2013

5. Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial;Mateos;J Clin Oncol,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapeutic palliation of bone marrow diseases—leukemia and multiple myeloma;Palliative Radiation Oncology;2024

2. Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma—A Critical Toxicity Evaluation in the Modern Treatment Era;Cancers;2023-05-25

3. Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations;Global Spine Journal;2023-04

4. Plasma Cell Disorders;Holland‐Frei Cancer Medicine;2022-10-21

5. RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment;Cancers;2022-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3